日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Computational analysis of visible frequency plasmonic properties of graphene on wide band gap heterostructures

宽带隙异质结构上石墨烯可见光频率等离子体特性的计算分析

Qamar, Muhammad; Abbas, Ghulam; Liao, Meiyong; Koizumi, Satoshi; Yamada, Takatoshi; Rezek, Bohuslav

Mechanistic modulation of electronic structure and interface chemistry in Ni-based alloys for electrochemical energy conversion

镍基合金电子结构和界面化学的机理调控及其在电化学能量转换中的应用

Nebel, Christoph E; Shin, Dongchan; Rezek, Bohuslav; Tokuda, Norio; Uetsuka, Hiroshi; Watanabe, Hideyuki; Ali Umar, Akrajas; Oyama, Munetaka

The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab

基线及早期外周血细胞比值动态变化在接受纳武利尤单抗治疗的转移性肾细胞癌患者中的预后作用

Fiala, Ondrej; Tkadlecova, Michaela; Kopecky, Jindrich; Hosek, Petr; Studentova, Hana; Vocka, Michal; Mateju, Martin; Lohynska, Radka; Sikova, Dominika; Stransky, Petr Jr; Kucera, Radek; Zemankova, Anezka; Spisarova, Martina; Priester, Peter; Kouril, Jan; Buchler, Tomas; Grmelova, Lucie; Melichar, Bohuslav; Poprach, Alexandr

Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum

利用血浆或血清脂质组学分析进行胰腺癌筛查方法的初步研究

Peterka, Ondřej; Jirásko, Robert; Dolečková, Zuzana; Dosoudilová, Mária; Bártl, Josef; Idkowiak, Jakub; Slavíček, Ondřej; Pešková, Karolína; Vošmik, Milan; Mohelníková-Duchoňová, Beatrice; Kozubíková, Irena; Loveček, Martin; Urban, Ondřej; Trna, Jan; Karásek, Petr; Melichar, Bohuslav; Holčapek, Michal

Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial

肾切除术后复发高风险局限性肾细胞癌辅助治疗:随机、安慰剂对照、III期CheckMate 914试验的B部分

Motzer, Robert J; Bex, Axel; Russo, Paul; Tomita, Yoshihiko; Cutuli, Hernan Javier; Rojas, Carlos; Gross-Goupil, Marine; Schinzari, Giovanni; Melichar, Bohuslav; Barthélémy, Philippe; Ruiz Garcia, Abraham; Sosman, Jeffrey; Grimm, Marc-Oliver; Goh, Jeffrey C; Suarez, Cristina; Kollmannsberger, Christian K; Nair, Suresh G; Shuch, Brian M; Huang, Jian; Simsek, Burcin; Spiridigliozzi, Julia; Lee, Chung-Wei; van Kooten Losio, Maximiliano; Grünwald, Viktor

Pentagonal Bipyramidal First-Row Transition Metal Complexes with Macrocyclic Ligand Containing Two Pyridine-N-Oxide Pendant Arms: Structural, Magnetic, and Theoretical Studies

具有两个吡啶-N-氧化物侧臂的大环配体的五角双锥第一行过渡金属配合物:结构、磁性和理论研究

Drahoš, Bohuslav; Šalitroš, Ivan; Herchel, Radovan

Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02

研究总结:曲妥珠单抗德鲁替康治疗HER2表达实体瘤的疗效(按入组HER2 IHC状态划分):DESTINY-PanTumor02研究的事后分析

Oaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; González-Martín, Antonio; Jung, Kyung Hae; Ługowska, Iwona; Manso, Luis; Manzano, Aránzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda

Asparagine-modified magnetic graphene oxide as efficient green nanocatalyst for synthesis of chromenes and pyrano pyrazoles derivatives.

天冬酰胺修饰的磁性氧化石墨烯作为高效绿色纳米催化剂用于合成色烯和吡喃并吡唑衍生物

Khaleghiabbasabadi Masoud, Azarifar Davood, Taghavian Hadi, Hematian Hadi, Silvestri Daniele, Rezek Bohuslav, Bahrami Behrokh, Khodabakhshi Saeed

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer

一项随机临床疗效和安全性研究,比较了peltopepimut-S联合cemiplimab与单用cemiplimab治疗复发/转移性HPV16阳性头颈癌患者的疗效和安全性。

Even, Caroline; Harrington, Kevin J; Massarelli, Erminia; Laban, Simon; Fayette, Jérôme; Oliva, Marc; Klein Hesselink, Marielle; Visscher, Sonja; Fury, Matthew G; Wiekmeijer, Anna-Sophia; Licitra, Lisa; Melichar, Bohuslav; Devriese, Lot A; Braña, Irene; Jankowska, Petra; Posner, Marshall; Glisson, Bonnie; Kong, Anthony; Hooftman, Leon; Melief, Cornelis J M MD,; Ferrarotto, Renata

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

仑伐替尼联合帕博利珠单抗对比舒尼替尼在晚期肾细胞癌一线治疗中的应用:III 期临床研究 CLEAR 的最终预设总生存期分析

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, María José Méndez-Vidal, Evgeny Kopyltsov, Sergei Tjulandin,